medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2005, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2005; 3 (2)

Adverse reactions of itraconazole and terbinafine. Presentation of two cases and brief review of literature

Fernández S, Arenas R, Domínguez-Soto L

Language: Spanish
References: 25
Page: 92-95
PDF size: 157.74 Kb.


ABSTRACT

We present two cases of drug eruption, one of them caused by terbinafine and the other due to itraconazole. Both patients were female with dermatological lesions affecting all the body segments and characterized by a morbilliform eruption or an urticariform reaction. Pharmacological surveillance should be a routinary method in these cases.


REFERENCES

  1. Katz HI. Drug interactions of the newer oral antifungal agents. Br J Dermatol 1999; 141 suppl 56: 26-32

  2. Texeira F, Arenas R. Interacciones medicamentosas en el tratamiento de las onicomicosis con itraconazol o fluconazol. Dermatología Rev Mex 1996; 40 (5): 340-344

  3. Gupta AK, Shear NH. A risk–benefit assessment of the newer oral antifungal agents used to treat onychomycosis. Drug Saf 2000; 22 (1): 33-52

  4. Johnstone D, Berger C, Fleckman P. Acute fulminant hepatitis after treatment with rabeprazole and terbinafine. Arch Intern Med 2001; 161 (13): 1677-1678

  5. Agarwal K, Manas DM, Hudson M. Terbinafine and fulminant hepatic failure. N Engl J Med 1999; 340 (16): 1292-1293

  6. Nores JM, Biacabe B, Bonfils P. Olfatory disorders due to medications: análisis and review of the literature. Rev Med Intern 2000; 21 (11): 972-977

  7. Schmutz JL, Barbaud A, Trechot P. Terbinafine-induced persistent agueusia: first reported case. Ann Dermatol Venereol 2000; 127 (3): 341

  8. Duxbury AJ, Oliver RJ, Pemberton MN. Persistent impairment of taste associated with terbinafine. Br Dent J 2000; 188 (6): 295-296

  9. Langers AM, Jonkers GJ. Pancreatitis ascribed to the use of itraconazole. Ned Tijdschr Geneeskd 2001; 145 (23): 1127-1128

  10. Castellsague J, García-Rodríguez L, Duque A et al. Risk of serious skin disorders among users of oral antifungals: a population-based study. BMC Dermatology 2002, 2: 14

  11. Taberner R, Puig L, Gilaberte M et al. Acute generalized exanthematous pustulosis induced by terbinafine. Eur J Dermatol 2003; 13 (3): 313-314

  12. Ghislain PD, Ghislain E. Fixed drug eruption due to fluconazole: a third case. J Am Acad Dermatol 2000; 42 (5 Pt 2): 883-884.

  13. Lane JE, Buckthal J, Davis LS. Fixed drug eruption due to fluconazole. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95 (2): 129-130

  14. Weiss JM, Mockenhaupt M, Schopf E et al. Reproducible drug exanthema to terbinafine with characteristic distribution of baboon syndrome. Hautarzt 2001; 52 (12): 1104-1106

  15. Martínez-Alonso JC, Domínguez-Ortega FJ, Fuentes-Gonzalo MJ. Urticaria and angioedema due to itraconazole. Allergy 2003; 58 (12): 1317-1318

  16. Alsadhan A, Taher M, Krol A. Acute generalized exanthematous pustulosis induced by oral fluconazole. J Cutan Med Surg. 2002; 6 (2): 122-124

  17. Fabre B, Albes B, Belhadjali H et al. Acute generalized exanthematous pustulosis due to fluconazole. Ann Dermatol Venereol 2002; 129 (3): 294-297

  18. Saissi EH, Beau-Salinas F, Jonville-Bera AP et al. Drugs associated with acute generalized exanthematic pustulosis. Ann Dermatol Venereol 2003; 130 (6-7): 612-618

  19. Lombardo M, Cerati M, Pazzaglia A. Acute generalized exanthematous pustulosis induced by terbinafine. J Am Acad Dermatol 2003; 49 (1): 158-159

  20. Hill VA, Chow J, Cowley N et al. Subacute lupus erythematosus-like eruption due to terbinafine: report of three cases. Br J Dermatol 2003; 148 (5): 1056

  21. Aksakal BA, Ozsoy E, Arnavut O et al. Oral terbinafine-induced bullous pemphigoid. Ann Pharmacother 2003; 37 (11): 1625-1627

  22. Álvarez-Fernández JG, Castaño Suárez E, Cornejo-Navarro P et al. Photosensitivity induced by oral itraconazole. J Eur Acad Dermatol Venereol 2000; 14 (6): 501-503

  23. Callen JP. Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized. J Am Acad Dermatol 2001; 45 (2): 315-316

  24. Szepietowski JC. Terbinafine exacerbates psoriasis: case report with a literature review. Acta Dermatovenereol Croat 2003; 11 (1): 17-21

  25. Ghislain P. Fixed drug eruption due to fluconazole; a third case. J Am Acad Dermatol 2002; 46 (3): 467




2020     |     www.medigraphic.com